The ventilator associated
pneumonia market, on the basis of end users, is segmented into hospitals,
research centers and clinics. Hospital segment dominates the global market
owing rising incidence of pneumonia and need for immediate medical assistance.
Ventilator-associated
pneumonia (VAP) is a type of pneumonia that happens after endotracheal
incubation, featured by the presence of a new or progressive virus. VAP is
predicted to occur in quarter of all mechanically ventilated patients along
with higher risk of being early in course of hospitalization. Risk for VAP is
greatest during the first initial days of mechanical ventilation between the
intubation and development of VAP. In the recent years, the accumulated risk of
death has decreased and is more recently estimated at a significant percentage.
View Full Report with TOC @ https://www.millioninsights.com/industry-reports/ventilator-associated-pneumonia-vap-market
VAP is a serious complication
of mechanical ventilation which increases the patient’s stay in ICU and overall
length of hospital incurs additional costs and is a most common of all
nosocomial infections contributing to death. The risk factor is the
endotracheal tube as mechanical ventilator support cannot be performed without
the endotracheal tube. The endotracheal tube provides a direct passageway into
the lungs, that bypasses natural protection mechanisms. Hence, the endotracheal
tube augments the risk for VAP by; preventing cough, preventing upper airway
filtering, preventing upper airway humidification, having a cuff that provides
a place for secretions to pool in the hypoglottic area.
The key driving factors
responsible for the growth of ventilator associated pneumonia market includes
growth in geriatric population and rising number of pneumonic patients
especially in the cold countries. Additionally, government funding to eradicate
lack of medical infrastructure for sparsely populated areas is also
contributing to the growth of ventilator associated pneumonia market. On the
basis of diagnosis types, the ventilator associated pneumonia market is
segmented into clinical, radiological and microbiological. Clinical segment
dominated the global ventilator associated pneumonia market owing to growth in
number of pneumonic patients.
On the basis of geographic
segmentation, the global associated ventilator pneumonia market spans North
America, Europe, China, Southeast Asia, Japan and India. North America
dominates the global market due to growth in increasing rates of pneumonias.
Europe is the second large market for ventilator-associated pneumonia (VAP) and
is witnessed a higher CAGR during the assessment period. APAC regions also
witnessed a higher CAGR growth during the assessment period. The key players in
the global ventilator associated pneumonia market include Philips Respironics,
Tyco, Hoffrichter, ResMed, Teleflex, Weinmann, Fisher & Paykel, and SYSMED.
This report studies Ventilator
Associated Pneumonia (VAP) in Global market, especially in North America,
Europe, China, Japan, Southeast Asia and India, with production, revenue,
consumption, import and export in these regions, from 2011 to 2015, and
forecast to 2021.
Request a Sample
Copy of This Report @ https://www.millioninsights.com/industry-reports/ventilator-associated-pneumonia-vap-market/request-sample
Comments
Post a Comment